Seyltx
Pharmaceutical Manufacturing
Refractory Chronic Cough - a Condition That 4-5 Million People in the Us Alone Suffers From.
3 employees
- Employees
- 3
- Contacts
- 1
- Emails
- 1
Seyltx Overview
- Headquarters
- Refractory Chronic Cough - a Condition That 4-5 Million People in the Us Alone Suffers From.
- Website
- www.seyltx.com
- Industry
- Pharmaceutical Manufacturing
- Employees
- 3
- Founded
- 2023
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation Manufacturing
Keywords
About Seyltx
Seyltx is a late clinical-stage pharmaceutical company leveraging new insights into how the brain functions to selectively target the "master switch" of the cough reflex to address refractory chronic cough - a condition that 4-5 million people in the US alone suffers from.
Seyltx Contact Details
- People in AeroLeads
- 3
- With contact data
- 1
- Email contacts
- 1
- 33.3% coverage
Seyltx Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Dietrich Stephan | Building Solutions to End Human | United States |
View
|
| Michael Bassoff | Relationship Builder, Founder |
View
|
|
| Parag Shah | Biotech COO - Strategic Leadership | New York City Metropolitan Area, United States |
Email
|
Employees by Management Level
Executive
2 profiles
Individual contributor
1 profile
Compare Similar Companies to Seyltx
Paratek Pharmaceuticals
Pharmaceutical Manufacturing
Wobble Genomics Ltd
Biotechnology Research
Biogenesis
Biotechnology
Peptilogics
Biotechnology
Axalbion Therapeutics Limited
Pharmaceutical Manufacturing
NeurOp, Inc.
Biotechnology Research
Cellara Biotechnology
Biotechnology Research
Archer Precision Medicine Advisory LLC
Business Consulting And Services
Collabrity
Biotechnology Research
Gambit Bio LLC
Biotechnology Research